BioPharma Resources

Investigational drug · Phase 3

BCG

Not approved by FDA. In 8 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Non-muscle Invasive Bladder Cancer (NMIBC), Papillary-Only Non-muscle-invasive Bladder Cancer, Tuberculosis.

Phase 3

Last checked: Nov 19, 2026Latest source record: Sep 8, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

8

8 still active

All registered trials

435

Any phase or sponsor naming "BCG"

First trial start

2014

Jul 21, 2014

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "BCG", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Non-muscle Invasive Bladder Cancer (NMIBC)
  • Papillary-Only Non-muscle-invasive Bladder Cancer
  • Tuberculosis
  • Bladder Cancer
  • NMIBC
  • Non-muscle Invasive Bladder Cancer
  • Non-Muscle- Invasive Bladder Cancer

Approved drugs for the same conditions: Bladder and urothelial cancer · Tuberculosis · Oncology · Infectious disease and vaccines · Kidney and urology

Largest trials

Live from ClinicalTrials.gov: studies naming "BCG" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 29,154 on PubMed

Also in development for Non-muscle Invasive Bladder Cancer (NMIBC)

  • FL115Phase 22 trials

    Suzhou Forlong Biotechnology Co., Ltd · Advanced Solid Tumors, Non-muscle Invasive Bladder Cancer (NMIBC)

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.